Startseite Medizin Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome

  • Panagiota Triantafyllou , Euthymia Vargiami , Isidora Vagianou , Maria Badouraki , Cecile Julier und Dimitrios I. Zafeiriou EMAIL logo
Veröffentlicht/Copyright: 23. Mai 2014

Abstract

Wolcott-Rallison syndrome (WRS) is a very rare genetic disorder, which is transmitted by autosomal recessive inheritance and results from mutations in the gene encoding the eukaryotic initiation factor 2-α kinase-3 (EIF2AK3). The cardinal features of the syndrome include early-onset insulin-dependent diabetes mellitus, multiple epiphyseal dysplasia, and growth retardation. We present the case of a 13-year-old Greek boy with a known history of infancy-onset diabetes mellitus and was found to have WRS at the age of 4 years. He presented with acute liver and renal insufficiency in addition to skeletal dysplasia and neurodevelopmental retardation. The clinical suspicion of WRS was confirmed by molecular analysis of the EIF2AK3 gene. The patient was found to be a compound heterozygote with two different novel mutations (c.2776C>T, p.R902X and c.3038A>G, p.Y989C). The current patient is one of the longer survivors.


Corresponding author: Dimitrios I. Zafeiriou, MD, PhD, Professor in Child Neurology and Developmental Pediatrics, First Department of Pediatrics, Aristotle University of Thessaloniki, Egnatia Street 106, 54622 Thessaloniki, Greece, Phone/Fax: 0030 2310 241845, E-mail: ;

References

1. Wolcott CD, Rallison ML. Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972;80:292–7.10.1016/S0022-3476(72)80596-1Suche in Google Scholar

2. Al-Shawi M, Al Mutair A, Ellard S, Habeb AM. Variable phenotype in five patients with Wolcott-Rallison syndrome due to the same EIF2AK3 (c.1259delA) mutation. J Pediatr Endocrinol Metab 2013;26:757–60.Suche in Google Scholar

3. Julier C, Nicolino M. Wolcott-Rallison. Orphanet J Rare Dis 2010;5:29–51.10.1186/1750-1172-5-29Suche in Google Scholar PubMed PubMed Central

4. Ozbek MN, Senée V, Aydemir S, Kotan LD, Mungan NO, et al. Wolcott-Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature. Pediatr Diabetes 2010;11:279–85.10.1111/j.1399-5448.2009.00591.xSuche in Google Scholar PubMed

5. Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 2009;94:4162–70.10.1210/jc.2009-1137Suche in Google Scholar PubMed PubMed Central

6. Senée V, Vattem KM, Delépine M, Rainbow LA, Haton C, et al. Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004;53:1876–83.10.2337/diabetes.53.7.1876Suche in Google Scholar PubMed

7. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, et al. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000;25:406–9.10.1038/78085Suche in Google Scholar PubMed

8. Brickwood S, Bonthron DT, Al-Gazali LI, Piper K, Hearn T, et al. Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet 2003;40:685–9.10.1136/jmg.40.9.685Suche in Google Scholar PubMed PubMed Central

9. Al-Gazali LI, Makia S, Hall CM. Wolcott-Rallison syndrome. Clin Dysmorphol 1995;4:227–33.10.1097/00019605-199507000-00006Suche in Google Scholar

10. Marafie MJ, Redha MA, Al-Naggar RL. Wolcott-Rallison syndrome in a Bedouin boy. Ann Saudi Med 2004;24:476–9.10.5144/0256-4947.2004.476Suche in Google Scholar PubMed PubMed Central

11. Bin-Abbas A, Shahib S, Hainau B, Al-Ashwal A. Wolcott-Rallison syndrome: clinical, radiological and histological findings in a Saudi child. Ann Saudi Med 2001;21:73–4.10.5144/0256-4947.2001.73Suche in Google Scholar PubMed

12. Biason-Lauber A, Lang-Muritano M, Vaccaro T, Schoenle EJ. Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene. Diabetes 2002;51:2301–05.10.2337/diabetes.51.7.2301Suche in Google Scholar PubMed

13. De Wit MC, de Coo IF, Julier C, Delépine M, Lequin MH, et al. Microcephaly and simplified gyral pattern of the brain associated with early onset insulin-dependent diabetes mellitus. Neurogenetics 2006;7:259–63.10.1007/s10048-006-0061-1Suche in Google Scholar PubMed

14. Iyer S, Korada M, Rainbow L, Kirk J, Brown RM, et al. Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr 2004;93:1195–201.10.1111/j.1651-2227.2004.tb02748.xSuche in Google Scholar

15. Bin-Abbas B, Al-Mulhim A, Al-Ashwal A. Wolcott-Rallison syndrome in two siblings with isolated central hypothyroidism. Am J Med Genet 2002;111:187–90.10.1002/ajmg.10495Suche in Google Scholar PubMed

16. Zhang P, McGrath B, Li S, Frank A, Zambito F, et al. The PERK eukaryotic initiation factor 2α kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 2002;22:3864–74.10.1128/MCB.22.11.3864-3874.2002Suche in Google Scholar PubMed PubMed Central

Received: 2013-12-10
Accepted: 2014-4-7
Published Online: 2014-5-23
Published in Print: 2014-9-20

©2014 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Heruntergeladen am 6.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0469/html
Button zum nach oben scrollen